🇺🇸 Ibuprofen + Paracetamol in United States
40 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 40
Most-reported reactions
- Off Label Use — 5 reports (12.5%)
- Pain — 5 reports (12.5%)
- Abdominal Pain — 4 reports (10%)
- Asthenia — 4 reports (10%)
- Nausea — 4 reports (10%)
- Pneumonia — 4 reports (10%)
- Pyrexia — 4 reports (10%)
- Vomiting — 4 reports (10%)
- Cough — 3 reports (7.5%)
- Diarrhoea — 3 reports (7.5%)
Ibuprofen + Paracetamol in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain Management approved in United States
Frequently asked questions
Is Ibuprofen + Paracetamol approved in United States?
Ibuprofen + Paracetamol does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Ibuprofen + Paracetamol in United States?
Ullevaal University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.